Mark your calendar and make sure you wear your spookiest costume to Monster Mash from 5 to 6:30 p.m. Thursday in the green space beside Discovery World at 900 Market St. The event returns as a ...

CSL), Jellinek wrote it was likely to be a beneficiary or at least insulated from any US tariffs on pharmaceuticals given its strong US operational footprint in plasma collection, fractionation, and ...

Earlier this year, a low-key biomedical firm briefly toppled Australia's biggest bank and miner to become the country's most expensive company and a household brand, thanks to its part in the race to ...

CSL isn't just another healthcare stock, it is a world leader in plasma-derived therapies, influenza vaccines, and specialty ...

Japan's Takeda Pharmaceutical Co said on Friday an alliance of drugmakers it spearheads has enrolled its first patient in a global clinical trial of a blood plasma treatment for COVID-19 after months ...

CSL and Telix expect no material impact from the fresh duties imposed on pharmaceutical products in a surprise announcement ...

Smaller rivals of the Australian plasma therapeutics group are pushing ahead with plans to build manufacturing facilities in the US, despite tariff uncertainty.

CSL Ltd (ASX: CSL) shares have taken a tumble this year. Is this the time to buy or should you keep your powder dry?

As CSL embarks on a restructuring drive to save more than $500 million annually over the next three years, the Australian ...

Australian biotechnology giant CSL Limited is in free fall, losing $2.4bn in early morning trading, after Donald Trump announced he will slap a 100 per cent tariff on pharmaceutical goods not made in ...

CSL Behring Canada Inc., a business unit of global biopharma leader CSL, today announced that it has signed a Letter of Intent (LOI) with the pan-Canadian Pharmaceutical Alliance (pCPA) for the public ...

The NSW Supreme Court has ruled in favour of Mayne Pharma, in a stoush over suitor Cosette's now-reluctant $670 million takeover offer.